1Camm AJ,Kirchhof P,Lip GY,et al.Guidelines for the management of atrial fibrillation:The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).Eur Heart J,2010,31(19):2369-2429.
2Fuster V,Rydén LE,Cannom DS,et al.ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary:a report of the American College of Cardiology /American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation).Eur Heart J,2006,27(16):1979-2030.
3Olson TM,Michels VV,Ballew JD,et al.Sodium channel mutations and susceptibility to heart failure and atrial fibrillation.JAMA,2005,293:447-454.
4Chen YH,Xu SJ,Bendahhou S,et al.KCNQ1 gain-of-function mutation in familialatrial fibrillation.Science,2003,299(5604):251-254.
5Gudbjartsson DF,Holm H,Gretarsdottir S,et al.A sequence variant in ZFHX3 on 16q22 associates with atrial ? brillation and ischemic stroke.Nat Genet,2009,41:876-878.
